Gregory Divis

Dr. Gregory J.
Divis is a Chief Executive Officer & Director at Mentari Therapeutics, Inc., a Chief Executive Officer & Director at Mentari Therapeutics, Inc. /New/ and a President at Marchem Northeast, Inc. He is on the Board of Directors at Mentari Therapeutics, Inc., Mentari Therapeutics, Inc. /New/, Health eVillages, Inc. and Mobius Therapeutics LLC.
Dr. Divis was previously employed as an Independent Director by Jaguar Health, Inc., a Chief Executive Officer & Director by Avadel Pharmaceuticals Plc, an Operating Partner by Linden Manager LLC, a President & Chief Executive Officer by Lumara Health Services Ltd., a President, Chief Executive Officer & Director by K-V Generic Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by AMAG Pharma USA, Inc., a VP-Business Development & Life Cycle Management by Sanofi-Aventis U.S.
LLC, a President by RB Rubber Products, Inc., a Vice President & General Manager-UK & Ireland by Schering-Plough Corp.
USA, a Chief Commercial Officer & Executive VP by Avadel Management Corp., and a Principal by Schering-Plough Ltd. He also served on the board at Tolero Pharmaceuticals, Inc. and Accella Performance Materials, Inc. He received his undergraduate degree from the University of Iowa.